Physician profile
Matthew Applebaum
NPI 1073044178
$5,267.41
in general payments reported to CMS, 2019-2025
19 companies · $3,883 in 2025
The $3,883 reported for 2025 was more than what 91% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.57 · 2022: $183 · 2023: $344 · 2024: $775 · 2025: $3,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,518 · Food and Beverage: $2,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,518.21 |
| Food and Beverage | $2,484.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $3,667.77 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $559.49 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Integra Lifesciences Corporation | $160.17 | 2022-2024 | Integra, Surgimend, Omnigraft |
| Tela Bio, INC. | $143.63 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $128.54 | 2022-2024 | Irrisept |
| Musculoskeletal Transplant Foundation INC. | $110.24 | 2025 | |
| Medtronic, INC. | $82.57 | 2021 | |
| Depuy Synthes Sales INC. | $51.23 | 2025 | Matrixmandible, Matrixwave |
| Axogen | $51.10 | 2025 | |
| Janssen Biotech, INC. | $47.41 | 2023-2024 | Tremfya |
| Sun Pharmaceutical Industries INC. | $45.53 | 2024 | |
| Organogenesis INC. | $45.50 | 2025 | Cygnus Dual, Via Matrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.04 | 2024-2025 | Spevigo |
| Lilly USA, LLC | $31.95 | 2024 | Olumiant, Taltz |
| Convatec INC. | $26.29 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $24.38 | 2023 | Aponvie |
| Fresenius Kabi USA, LLC | $20.62 | 2024 | Idacio |
| Stryker Corporation | $18.95 | 2024 | 1788 |
| Medical Device Business Services, INC. | $16.00 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Applebaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.